A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus Retinitis
Daniel Martín(University of Leeds), Mary Jean Stempien(Palo Alto Institute), Panos Georgiou(Roche (United Kingdom)), Katherine Macey(Roche (United Kingdom)), Juan Sierra‐Madero(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Sharon Walmsley(University Health Network), Charles A. Robinson(Center for Global Development), Richard A. Wolitz(Kaiser Permanente San Francisco Medical Center)
Cited by 394
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2008|1k
Sjögren's syndrome. Proposed criteria for classification
|Arthritis & Rheumatism|1986|685
Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients
|The Lancet|1997|501
Oral Ganciclovir for Patients with Cytomegalovirus Retinitis Treated with a Ganciclovir Implant
|New England Journal of Medicine|1999|485
Mpox in people with advanced HIV infection: a global case series
|The Lancet|2023|482